List of Tables
Table 1. Global Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Inotersen
Table 3. Key Players of Tafamidis
Table 4. Key Players of Patisiran
Table 5. Key Players of Others
Table 6. Global Familial Amyloid Polyneuropathy Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Region (2020-2025)
Table 10. Global Familial Amyloid Polyneuropathy Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Region (2026-2031)
Table 12. Familial Amyloid Polyneuropathy Therapeutic Market Trends
Table 13. Familial Amyloid Polyneuropathy Therapeutic Market Drivers
Table 14. Familial Amyloid Polyneuropathy Therapeutic Market Challenges
Table 15. Familial Amyloid Polyneuropathy Therapeutic Market Restraints
Table 16. Global Familial Amyloid Polyneuropathy Therapeutic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Players (2020-2025)
Table 18. Global Top Familial Amyloid Polyneuropathy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Amyloid Polyneuropathy Therapeutic as of 2024)
Table 19. Ranking of Global Top Familial Amyloid Polyneuropathy Therapeutic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Familial Amyloid Polyneuropathy Therapeutic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Familial Amyloid Polyneuropathy Therapeutic, Headquarters and Area Served
Table 22. Global Key Players of Familial Amyloid Polyneuropathy Therapeutic, Product and Application
Table 23. Global Key Players of Familial Amyloid Polyneuropathy Therapeutic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Type (2020-2025)
Table 27. Global Familial Amyloid Polyneuropathy Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Type (2026-2031)
Table 29. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Application (2020-2025)
Table 31. Global Familial Amyloid Polyneuropathy Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Familial Amyloid Polyneuropathy Therapeutic Revenue Market Share by Application (2026-2031)
Table 33. North America Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Pfizer Inc. Company Details
Table 49. Pfizer Inc. Business Overview
Table 50. Pfizer Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 51. Pfizer Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 52. Pfizer Inc. Recent Development
Table 53. Alnylam Pharmaceuticals Inc. Company Details
Table 54. Alnylam Pharmaceuticals Inc. Business Overview
Table 55. Alnylam Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 56. Alnylam Pharmaceuticals Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 57. Alnylam Pharmaceuticals Inc. Recent Development
Table 58. Ionis Pharmaceuticals Inc. Company Details
Table 59. Ionis Pharmaceuticals Inc. Business Overview
Table 60. Ionis Pharmaceuticals Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 61. Ionis Pharmaceuticals Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 62. Ionis Pharmaceuticals Inc. Recent Development
Table 63. Corino Therapeutics Inc. Company Details
Table 64. Corino Therapeutics Inc. Business Overview
Table 65. Corino Therapeutics Inc. Familial Amyloid Polyneuropathy Therapeutic Product
Table 66. Corino Therapeutics Inc. Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 67. Corino Therapeutics Inc. Recent Development
Table 68. Proclara Biosciences Company Details
Table 69. Proclara Biosciences Business Overview
Table 70. Proclara Biosciences Familial Amyloid Polyneuropathy Therapeutic Product
Table 71. Proclara Biosciences Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 72. Proclara Biosciences Recent Development
Table 73. Arcturus Therapeutics Inc Company Details
Table 74. Arcturus Therapeutics Inc Business Overview
Table 75. Arcturus Therapeutics Inc Familial Amyloid Polyneuropathy Therapeutic Product
Table 76. Arcturus Therapeutics Inc Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 77. Arcturus Therapeutics Inc Recent Development
Table 78. Prothena Corporation Company Details
Table 79. Prothena Corporation Business Overview
Table 80. Prothena Corporation Familial Amyloid Polyneuropathy Therapeutic Product
Table 81. Prothena Corporation Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 82. Prothena Corporation Recent Development
Table 83. Eidos Therapeutics Company Details
Table 84. Eidos Therapeutics Business Overview
Table 85. Eidos Therapeutics Familial Amyloid Polyneuropathy Therapeutic Product
Table 86. Eidos Therapeutics Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 87. Eidos Therapeutics Recent Development
Table 88. FoldRx Pharmaceuticals Company Details
Table 89. FoldRx Pharmaceuticals Business Overview
Table 90. FoldRx Pharmaceuticals Familial Amyloid Polyneuropathy Therapeutic Product
Table 91. FoldRx Pharmaceuticals Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 92. FoldRx Pharmaceuticals Recent Development
Table 93. Akcea Therapeutics Company Details
Table 94. Akcea Therapeutics Business Overview
Table 95. Akcea Therapeutics Familial Amyloid Polyneuropathy Therapeutic Product
Table 96. Akcea Therapeutics Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 97. Akcea Therapeutics Recent Development
Table 98. GlaxoSmithKline (GSK) Company Details
Table 99. GlaxoSmithKline (GSK) Business Overview
Table 100. GlaxoSmithKline (GSK) Familial Amyloid Polyneuropathy Therapeutic Product
Table 101. GlaxoSmithKline (GSK) Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 102. GlaxoSmithKline (GSK) Recent Development
Table 103. Greenovation Biotech GmbH Company Details
Table 104. Greenovation Biotech GmbH Business Overview
Table 105. Greenovation Biotech GmbH Familial Amyloid Polyneuropathy Therapeutic Product
Table 106. Greenovation Biotech GmbH Revenue in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025) & (US$ Million)
Table 107. Greenovation Biotech GmbH Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Familial Amyloid Polyneuropathy Therapeutic Picture
Figure 2. Global Familial Amyloid Polyneuropathy Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Type: 2024 VS 2031
Figure 4. Inotersen Features
Figure 5. Tafamidis Features
Figure 6. Patisiran Features
Figure 7. Others Features
Figure 8. Global Familial Amyloid Polyneuropathy Therapeutic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Application: 2024 VS 2031
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Others Case Studies
Figure 14. Familial Amyloid Polyneuropathy Therapeutic Report Years Considered
Figure 15. Global Familial Amyloid Polyneuropathy Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Familial Amyloid Polyneuropathy Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Region: 2024 VS 2031
Figure 18. Global Familial Amyloid Polyneuropathy Therapeutic Market Share by Players in 2024
Figure 19. Global Top Familial Amyloid Polyneuropathy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Amyloid Polyneuropathy Therapeutic as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Familial Amyloid Polyneuropathy Therapeutic Revenue in 2024
Figure 21. North America Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2020-2031)
Figure 23. United States Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2020-2031)
Figure 27. Germany Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Familial Amyloid Polyneuropathy Therapeutic Market Share by Region (2020-2031)
Figure 35. China Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2020-2031)
Figure 43. Mexico Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Familial Amyloid Polyneuropathy Therapeutic Market Share by Country (2020-2031)
Figure 47. Turkey Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Familial Amyloid Polyneuropathy Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Pfizer Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 52. Ionis Pharmaceuticals Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 53. Corino Therapeutics Inc. Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 54. Proclara Biosciences Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 55. Arcturus Therapeutics Inc Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 56. Prothena Corporation Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 57. Eidos Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 58. FoldRx Pharmaceuticals Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 59. Akcea Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 60. GlaxoSmithKline (GSK) Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 61. Greenovation Biotech GmbH Revenue Growth Rate in Familial Amyloid Polyneuropathy Therapeutic Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
